Selecta Biosciences, Inc.:
Immune tolerance platform (ImmTOR) developed in combo with rare disease therapies. SEL-212 (chronic refractory gout) in COMPARE Ph 2 trial vs KRYSTEXXA®; topline data mid-2020. Gene tx pipeline in preclinical development with ImmTOR where re-dosing require. AskBio collab.
US - New England
Phase l or ll
100MM - 500MM
480 Arsenal Way
Watertown, MA 02472
Top 10 Holders of Selecta Biosciences, Inc.
Ownership data is sourced through FactSet.
Stock Market Data
Market Data copyright © 2020 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by